Darong Wu

机构：Guangzhou University of Chinese Medicine · ORCID：0000-0003-3159-7359

发表论文 111 篇 · 总被引 2325 次 · h-index 22

代表论文

• Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models (2021 · Science Translational Medicine · 被引 147)
• Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients (2021 · Nature Communications · 被引 79)
• Acupuncture for cancer pain: an evidence-based clinical practice guideline (2022 · Chinese Medicine · 被引 71)
• Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β (2022 · Frontiers in Immunology · 被引 57)
• Integrating Chinese and western medicine for COVID‐19: A living evidence‐based guideline (version 1) (2021 · Journal of Evidence-Based Medicine · 被引 34)
• Self-driving armored CAR-T cells overcome a suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical models (2021 · Molecular Therapy · 被引 31)